Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.020
-0.170 (-14.29%)
At close: Aug 12, 2026, 4:00 PM EDT
1.080
+0.060 (5.88%)
After-hours: Aug 12, 2026, 7:37 PM EDT
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,771,511
Market Cap
115.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Connect Biopharma Holdings | 64 |
| Vivani Medical | 42 |
| TuHURA Biosciences | 22 |
| Unicycive Therapeutics | 22 |
| Equillium | 15 |
| Spruce Biosciences | 14 |
| Canton Strategic Holdings | 12 |
INDP News
- 27 days ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Indaptus Therapeutics files to sell 18.86M shares of common stock for holders - TheFly
- 6 weeks ago - Indaptus Therapeutics Registration statement: Registration filing - Filings
- 7 weeks ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 7 weeks ago - Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders - GlobeNewsWire
- 3 months ago - Indaptus Therapeutics Quarterly report: Q1 2026 - Filings
- 3 months ago - Indaptus Therapeutics Earnings release: Q1 2026 - Filings
- 3 months ago - Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire